AMPH vs L · P/E 12, rev $732.0M vs P/E 14, rev $18.45B
Amphastar P (AMPH) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the AMPH and L stock pages for the full models.
Not investment advice.